Sanofi Pasteur MSD: Zostavax® Shingles Vaccine Wins UK Tender Renewal
LYON, France, September 28, 2016 /PRNewswire/ -- Zostavax® shingles vaccine remains as part of the successful UK national immunisation programme for the next two years. Sanofi Pasteur MSD today an...
Read full article »
CEO
Sanofi Pasteur MSD is a Private company. Sanofi Pasteur MSD has a revenue of $10M, and 10 employees. Sanofi Pasteur MSD has 3 followers on Owler.